| 2026-03-30 |
股东大会：
将于2026-05-12召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors, Matthew Fisch and Doron Simon, each to hold office until our Annual Meeting of Stockholders in 2029 and until his successor is duly elected and qualified, or until his earlier death, resignation, or removal
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026
3.To approve an increase in the number of shares of common stock issuable under our 2021 Equity Incentive Plan
4.To approve, on an advisory and non-binding basis, the compensation of our named executive officers
5.To determine, on an advisory and non-binding basis, on how frequently the stockholders will be provided a “say-on-pay” vote, either every one, two or three years
6.To transact other business that may properly come before the Annual Meeting, or any adjournments or postponements thereof
|
| 2026-03-18 |
详情>>
股本变动：
变动后总股本4534.59万股
|
| 2026-03-18 |
详情>>
业绩披露：
2025年年报每股收益-1.47美元,归母净利润-3395.8万美元,同比去年增长4.24%
|
| 2026-03-16 |
财报披露：
美东时间 2026-03-16 盘后发布财报
|
| 2026-02-15 |
详情>>
内部人交易：
Fisch Matthew等共交易3笔
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.34美元,归母净利润-2661.6万美元,同比去年增长1.10%
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-0.95美元,归母净利润-1728.6万美元,同比去年增长5.05%
|
| 2025-07-28 |
复牌提示：
2025-07-28 09:51:37 停牌，复牌日期 2025-07-28 10:01:37
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.46美元,归母净利润-801.6万美元,同比去年增长21.56%
|
| 2025-04-07 |
股东大会：
将于2025-05-15召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, or removal;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve an increase in the number of shares of common stock issuable under our 2021 Equity Incentive Plan;
4.To consider and vote upon an advisory stockholder proposal to declassify the Board structure, described below, if properly presented at the meeting;
5.To consider and vote upon an advisory stockholder proposal to reduce the number of authorized shares of common stock, described below, if properly presented at the meeting;
6.To transact other business that may properly come before the Annual Meeting, or any adjournments or postponements thereof.
|
| 2025-02-24 |
详情>>
业绩披露：
2024年年报每股收益-4.89美元,归母净利润-3546万美元,同比去年增长59.30%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.9美元,归母净利润-2691.2万美元,同比去年增长54.65%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-2.8美元,归母净利润-1820.6万美元,同比去年增长56.96%
|
| 2024-05-14 |
详情>>
业绩披露：
2024年一季报每股收益-1.61美元,归母净利润-1021.9万美元,同比去年增长61.09%
|
| 2024-04-02 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class III directors, Prof. Dr. Bernd Gottschalk and Jonathon B. Husby, each to hold office until our Annual Meeting of Stockholders in 2027 and until his successor is duly elected and qualified, or until his earlier death, resignation, or removal;
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve an increase in the number of shares of common stock issuable under our 2021 Equity Incentive Plan;
4.To transact other business that may properly come before the Annual Meeting, or any adjournments or postponements thereof.
|
| 2024-03-27 |
详情>>
业绩披露：
2023年年报每股收益-14.95美元,归母净利润-8712.6万美元,同比去年增长11.74%
|
| 2023-12-27 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.34美元,归母净利润-5934.4万美元,同比去年增长20.85%
|
| 2023-10-31 |
股东大会：
将于2023-12-12召开股东大会
会议内容 ▼▲
- 1.To approve a series of ten alternative potential amendments, in the form of Annex A to the accompanying proxy statement, to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to authorize the Company’s Board of Directors to effect a reverse stock split of the issued shares of our common stock, at ratios of one share of common stock for each multiple of five issued shares of our common stock between and including five and fifty, which ratio to become effective as determined by the Board of Directors if the Board of Directors subsequently determines to proceed with the reverse stock split (the “Reverse Stock Split,” and, such proposal, the “Reverse Stock Split Proposal”);
2.To adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the Reverse Stock Split in Proposal One.
|
| 2023-03-20 |
股东大会：
将于2023-05-03召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class II directors, Luis C. Dussan and Matthew Fisch, each to hold office until our Annual Meeting of Stockholders in 2026 and until his successor is duly elected and qualified, or until his earlier death, resignation, or removal;
2.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock;
4.To approve an increase in the number of shares of common stock issuable under our 2021 Equity Incentive Plan;
5.To approve an amendment to our Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by recent amendments to Delaware law;
6.To transact other business that may properly come before the Annual Meeting, or any adjournments or postponements thereof.
|
| 2022-03-31 |
股东大会：
将于2022-05-10召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class I directors, Timothy J. Dunn, Wen H. Hsieh, and Sue Zeifman, each to hold office until our Annual Meeting of Stockholders in 2025 and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, or removal;
2.To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To approve the adoption of the AEye, Inc. 2022 Employee Stock Purchase Plan;
4.To transact other business that may properly come before the Annual Meeting, or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-21 |
股东大会：
将于2021-08-12召开股东大会
会议内容 ▼▲
- 1.to approve an amendment to CF III’s current amended and restated certificate of incorporation (the “Existing Charter”) to increase the number of authorized shares of Class A Common Stock from 200,000,000 to 300,000,000 shares for the purposes of carrying out the Business Combination (as defined below);
2.to adopt and approve the Agreement and Plan of Merger, dated February 17, 2021, as amended on April 30, 2021 (the “Merger Agreement”), by and among CF III, Meliora Merger Sub, Inc. a Delaware corporation and a direct wholly owned subsidiary of CF III, and AEye, Inc., a Delaware corporation, and to approve the transactions contemplated thereby (the “Business Combination”);
3.to consider and vote upon a proposal to elect seven directors to serve on the board of directors of CF III following the Business Combination (the “Combined Entity”) until the next annual meeting of stockholders and until their respective successors are duly elected and qualified;
4. to approve, for purposes of complying with The Nasdaq Stock Market Listing Rule 5635, the issuance of up to 154,081,440 shares of Class A Common Stock pursuant to the Merger Agreement and up to 22,500,000 shares of Class A Common Stock pursuant to the PIPE Investment;
5.to approve separate proposals to amend and restate the Existing Charter to adopt certain material differences that will be in effect upon the consummation of the Business Combination;
6.to approve the Equity Incentive Plan of the Combined Entity (the “Equity Incentive Plan”) in connection with the Business Combination;
7.to approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary.
|